You are here
Johnson & Johnson forecasts profit decline this year on competition
JOHNSON & JOHNSON (J&J), the world's biggest maker of healthcare products, forecast lower earnings in 2015 as competition cuts into revenue for some of its best-selling drugs. The shares slumped the most in three months.
Adjusted profit this year will reach US$6.12
- CALL +65 6388 3838
- EMAIL email@example.com